UTILITY OF A PROLIFERATION MARKER IN DISTINGUISHING BETWEEN BENIGN NEVOCELLULAR NEVI AND NEVOCELLULAR NEVUS-LIKE LESIONS WITH MALIGNANT PROPERTIES

被引：25

作者：

KANTER, L ^{[1
]}

BLEGEN, H ^{[1
]}

WEJDE, J ^{[1
]}

LAGERLOF, B ^{[1
]}

LARSSON, O ^{[1
]}

机构：

[1] KAROLINSKA HOSP,DEPT TUMOR PATHOL,S-17176 STOCKHOLM,SWEDEN

来源：

MELANOMA RESEARCH | 1995年 / 5卷 / 05期

关键词：

BENIGN NEVOCELLULAR NEVUS; MIB1; MALIGNANT NEVOCELLULAR NEVUS-LIKE LESIONS; MELANOMA; PROLIFERATION MARKER;

D O I：

10.1097/00008390-199510000-00007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In the present study we have investigated the utility of the proliferation marker MIB1 in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant potential, Percentages of MIB1 immunoreactivity in the intradermal portion of the lesions were determined. In benign congenital and acquired naevi, as well as in dysplastic naevi, there was no or only a slight intradermal melanocytic proliferation (0-2%), whereas vertical growth phase melanomas exhibited a substantial proliferative activity (11-48%). In five cases of naevus-like lesions, which had all relapsed as unmistakable malignant melanomas (locally or metastatically) after primary surgery, there was also clear proliferative activity (9-67%). Our findings suggest that MIB1 may be a useful tool in the routine histopathological examination of problematic naevocellular lesions.

引用

页码：345 / 350

页数：6

共 15 条

[11]

Barnhill R.L., Pathology and prognostic factors, Curr Opin Oncol, 5, pp. 364-376, (1993)

[12]

Korabiowska M., Brinck U., Hoenig J.F., Et al., An application of MIB antibody to the retrospective study of melanomas of oral mucosa and facial skin, J Cancer Res Clin Oncol, 120, pp. 365-368, (1994)

[13]

Rieger E., Hofmann-Wellenhof R., Soyer H.P., Et al., Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study, J Cutan Pathol, 20, pp. 229-236, (1993)

[14]

Fogt F., Vortmeyer A.O., Tahan S.R., Nuclear organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions, Am J Dermatopathol, 17, pp. 12-17, (1995)

[15]

McGovern V.J., Melanoma. Histological Diagnosis and Prognosis, pp. 3-24, (1983)

← 1 2 →